The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.
Top 5 Upgrades:
Wells Fargo upgraded Ulta Beauty (ULTA) to Equal Weight from Underweight with a price target of $525, up from $450, after meeting with management. The firm says the company is navigating industry headwinds better than expected.
Oppenheimer upgraded Etsy (ETSY) to Outperform from Perform with a $90 price target. The firm cites the company's AI search benefits, product improvements, and app engagement for the upgrade.
Berenberg upgraded Eli Lilly (LLY) to Buy from Hold with a price target of $1,400, up from $1,220. The firm says its 2026 return on investment **** ysis confirms Eli Lilly's "strong track record of delivering best-in-class returns on investment."
Bernstein upgraded Agilon Health (AGL) to Outperform from Market Perform with a price target of $125, up from $86. The company is undergoing a turnaround focused on risk-taking discipline and incremental medical cost improvements, the firm tells investors in a research note.
#firm #outperform #perform
Top 5 Upgrades:
Wells Fargo upgraded Ulta Beauty (ULTA) to Equal Weight from Underweight with a price target of $525, up from $450, after meeting with management. The firm says the company is navigating industry headwinds better than expected.
Oppenheimer upgraded Etsy (ETSY) to Outperform from Perform with a $90 price target. The firm cites the company's AI search benefits, product improvements, and app engagement for the upgrade.
Berenberg upgraded Eli Lilly (LLY) to Buy from Hold with a price target of $1,400, up from $1,220. The firm says its 2026 return on investment **** ysis confirms Eli Lilly's "strong track record of delivering best-in-class returns on investment."
Bernstein upgraded Agilon Health (AGL) to Outperform from Market Perform with a price target of $125, up from $86. The company is undergoing a turnaround focused on risk-taking discipline and incremental medical cost improvements, the firm tells investors in a research note.
#firm #outperform #perform
2 months ago